期刊文献+

丹参素缓释微丸的制备及家兔体内药动学研究 被引量:5

Preparation of Danshensu Sustained-release Pellets and Their Pharmacokinetics in Rabbits
下载PDF
导出
摘要 目的:制备丹参素24 h缓释微丸并研究其在家兔体内的药动学行为。方法:采用挤出滚圆法制备丹参素含药丸芯,以尤特奇水分散体为缓释包衣材料进行流化床包衣制备缓释微丸,研究制剂在家兔体内药动学行为。结果:所得丹参素缓释微丸圆整度好,包衣均匀,体外达到24 h缓慢释放。家兔口服相同剂量的丹参素速释微丸和缓释微丸后,Cmax分别为(1.45±0.24)μg·mL-1和(0.67±0.13)μg·mL-1,Tmax分别为(2.00±0.30)h和(8.00±0.50)h,MRT分别为(3.50±0.25)h和(10.93±0.26)h。与丹参素速释微丸相比缓释微丸的相对生物利用度为111.28%±1.28%。结论:丹参素缓释微丸可以达到24 h缓释,以AUC为评价指标时,与丹参素速释微丸生物等效。 Objective: To prepare 24 h Danshensu sustained-release pellets, and further evaluate their in vivo pharmaeokineties. Methods: Danshensu sustained-release pellets were prepared by an extrusionspheronization technique and coated with Eduragit aqueous dispersion on a fluidized bed. /n vivo pharmaeokinetics was studied after oral administration of the Danshensu pellets to rabbits. Results: Spherical and uniformly coated pellets were obtained. The cumulated release percent of Danshensu sustained-release pellets in 24 h was more than 90%. The pharmacokinetic parameters for Danshensu immediate-release pellets and sustained-release pellets were respective as follows: peak plasma concentration (Cmax), 1.45±0.24 μg·mL-1and 0.67±0.13 μg·mL-1; time to peak concentration (Tmax), 2.00±0.30h and 8.00±0.50 h; mean residence time (MRT), 3.50±0.25 h and 10.93±0.26 h. Besides, the relative bioavailability of Danshensu sustained-release pellets was 111.28±1.28%. Conclusion: The Danshensu sustained-release pellets were up to the 24 h sustained-release standard and bioequivalent to the immediate-release pellets.
出处 《药学与临床研究》 2013年第2期105-108,共4页 Pharmaceutical and Clinical Research
基金 国家"重大新药创制"科技重大专项资助项目(No.2009ZX09310-004)
关键词 丹参素 缓释微丸 挤出滚圆 流化床 药代动力学 Danshensu Sustained-release pellet Extrusion-spheronization Fluidized bed Pharmacokineties
  • 相关文献

参考文献4

二级参考文献40

  • 1毕惠嫦,关溯,陈孝,齐慧敏,苏启表,黄民.隐丹参酮在小肠吸收机制的实验研究[J].中国临床药理学杂志,2005,21(2):107-110. 被引量:21
  • 2水文波,贺庆,邵青,程翼宇.高效液相色谱-质谱联用法研究丹酚酸B的大鼠小肠吸收[J].中国药学杂志,2006,41(7):545-547. 被引量:7
  • 3赵娜,郭治昕,赵雪,赵利斌.丹参的化学成分与药理作用[J].国外医药(植物药分册),2007,22(4):155-160. 被引量:256
  • 4Lane M E, Levis K A, Corrigan O I. Effect of intestinal fluid flux on ibuprofen absorption in the rat intestine [J]. Int J Pharm, 2006, 309(1/2): 60-66.
  • 5Jain R, Duvvuri S, Kansara V, et al. Intestinal absorption of novelodipeptide prodrugs of saquinavir in rats [J]. Int J Pharm, 2007, 336(2): 233-240.
  • 6Armitage P, Hills M. The two-period crossover trial [J]. The Statistic, 1982, 31(2): 119-131.
  • 7Yu L X, Lipka E, Crison J R, et al. Transport approaches to the biopharmaceutical design of oral drug delivery systems: prediction of intestinal absorption [J], Adv Drug Deliv Rev, 1996, 19(3): 359-376.
  • 8Krause J ,Thommes M, Breitkreutz J. Immediate release pellets with lipid binders obtained by solvent-free cold extrusion [ J ]. Eur J Pharm Biopharm ,2009,71 : 138.
  • 9Cheboyina S,Wyandt CM. Wax-based sustained release matrix pel- lets prepared by a novel freeze pelletization technique I. Formula- tion and process variables affecting pellet characteristics [ J ]. [nt J Pharm, 2008,359 ( 1-2 ) : ] 58.
  • 10Cheboyina S,Wyandt CM. Wax-based sustained release matrix pel- lets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms [ J ]. Int J Pharm, 2008,359 ( 1-2 ) : 167.

共引文献48

同被引文献59

引证文献5

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部